Cannabis Research A to Z |
Clinical Neuropsychologist Nicola Gates discusses what effects can be expected during the three phases of Alzheimer's Disease
Cannabis Research and Alzheimer's
MARIJUANA SLOWS ALZHEIMER'S DECLINE
Marijuana may block Alzheimer's
Prevention of Alzheimer's Disease Pathology by Cannabinoids
Marijuana's Active Ingredient Shown to Inhibit Primary Marker of Alzheimer's Disease
Safety and efficacy of Dronabinol in the treatment of agitation in patients with Alzheimer's disease with anorexia
Open-label study of Dronabinol in the treatment of refractory agitation in Alzheimer's disease
Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease
Cannabinoids reduce the progression of Alzheimer's disease in animals
Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
THC inhibits primary marker of Alzheimer's disease
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats
Alzheimer's disease; taking the edge off with cannabinoids?
US Patent 6630507 - Cannabinoids as antioxidants and neuroprotectants
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
Inflammation and aging: can endocannabinoids help?
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation
Marijuana reduces memory impairment
The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
Attacking Alzheimer's with Red Wine and Marijuana
Pot joins the fight against Alzheimer's, memory loss
|
No comments:
Post a Comment